- DOC Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K/A Filing
Healthpeak Properties (DOC) 8-K/AFinancial Statements and Exhibits
Filed: 19 Jan 11, 12:00am
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2010 AND FOR THE YEAR ENDED DECEMBER 31, 2009 AND THE
NINE MONTHS ENDED SEPTEMBER 30, 2010
| Page | |||
---|---|---|---|---|
Unaudited Pro Forma Condensed Consolidated Balance Sheet as of September 30, 2010 | 3 | |||
Unaudited Pro Forma Condensed Consolidated Statement of Operations for the nine months ended September 30, 2010 | 4 | |||
Unaudited Pro Forma Condensed Consolidated Statement of Operations for the year ended December 31, 2009 | 5 | |||
Notes to Unaudited Pro Forma Condensed Consolidated Financial Statements | 6 |
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The accompanying unaudited pro forma condensed consolidated financial statements presented below have been prepared based on certain pro forma adjustments to the historical consolidated financial statements of HCP, HCR ManorCare PropCo LLC ("HCR ManorCare PropCo") and HCP Ventures II as of and for the nine months ended September 30, 2010 and for the year ended December 31, 2009. The historical consolidated financial statements of HCP are contained in its Annual Report on Form 10-K for the year ended December 31, 2009, as updated by its Current Report on Form 8-K as filed with the SEC on November 2, 2010, and Quarterly Report on Form 10-Q for the quarter ended September 30, 2010. The historical consolidated financial statements of HCR ManorCare PropCo are included as Exhibits 99.2 and 99.3 to the Current Report on Form 8-K as filed with the SEC on December 14, 2010.
The accompanying unaudited pro forma condensed consolidated financial statements give effect to the proposed acquisition by HCP of all of the equity interest in HCR ManorCare PropCo (the "HCR ManorCare Facilities Acquisition") and the purchase of the remaining 65 percent interest in HCP Ventures II (the "HCP Ventures II Purchase") (collectively, the "Acquisitions"). The unaudited pro forma condensed consolidated balance sheet as of September 30, 2010 has been prepared as if the Acquisitions had occurred as of that date. The unaudited pro forma condensed consolidated statements of operations for the year ended December 31, 2009 and for the nine months ended September 30, 2010 have been prepared as if the Acquisitions had occurred as of January 1, 2009. Such statements also reflect the incurrence of debt and give effect to certain capital transactions undertaken by HCP in order to finance the Acquisitions.
The allocation of the purchase price of HCR ManorCare PropCo and HCP Ventures II reflected in these unaudited pro forma condensed consolidated financial statements has been based upon preliminary estimates of the fair value of assets acquired and liabilities assumed. A final determination of the fair values of HCR ManorCare PropCo's and HCP Ventures II's assets and liabilities will be based on the actual valuation of the tangible and intangible assets and liabilities of HCR ManorCare PropCo and HCP Ventures II that exist as of the date of completion of the transactions. Consequently, amounts preliminarily allocated to identifiable tangible and intangible assets and liabilities could change significantly from those used in the pro forma condensed consolidated financial statements presented below and could result in a material change in amortization of tangible and intangible assets and liabilities.
In the opinion of HCP's management, the pro forma financial statements include all significant necessary adjustments that can be factually supported to reflect the effects of the Acquisitions. The unaudited pro forma condensed consolidated financial statements are provided for informational purposes only. The unaudited pro forma condensed consolidated financial statements are not necessarily and should not be assumed to be an indication of the results that would have been achieved had the transactions been completed as of the dates indicated or that may be achieved in the future. The completion of the valuation, the allocation of the purchase price, the impact of ongoing integration activities, the timing of completion of the transactions and other changes in HCR ManorCare PropCo and HCP Ventures II tangible and intangible assets and liabilities that occur prior to completion of the transactions could cause material differences in the information presented. Furthermore, following consummation of the transactions, HCP expects to apply its own methodologies and judgments in accounting for the assets and liabilities acquired in the transaction, which may differ from those reflected in HCR ManorCare PropCo's and HCP Ventures II's historical financial statements and the pro forma financial statements.
2
HCP, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
SEPTEMBER 30, 2010
| HCP Historical | HCR ManorCare PropCo Historical (A) | HCR ManorCare PropCo Pro Forma Adjustments (B) | HCP Ventures II Historical (A) | HCP Ventures II Pro Forma Adjustments (P) | HCP Pro Forma | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands) | ||||||||||||||||||||||
ASSETS | |||||||||||||||||||||||
Real estate: | |||||||||||||||||||||||
Buildings, improvements and development | $ | 8,260,220 | $ | — | $ | — | $ | 936,957 | $ | (249,404 | )(Q) | $ | 8,947,773 | ||||||||||
Land | 1,558,947 | — | — | 108,907 | (14,835 | )(Q) | 1,653,019 | ||||||||||||||||
Accumulated depreciation and amortization | (1,189,998 | ) | — | — | (105,085 | ) | 105,085 | (Q) | (1,189,998 | ) | |||||||||||||
Net real estate | 8,629,169 | — | — | 940,779 | (159,154 | ) | 9,410,794 | ||||||||||||||||
Net investment in direct financing leases | 607,392 | 3,123,630 | 2,883,005 | (C) | — | — | 6,614,027 | ||||||||||||||||
Loans receivable, net | 1,852,521 | — | (1,578,697 | )(D) | — | — | 273,824 | ||||||||||||||||
Investments in and advances to unconsolidated joint ventures | 197,697 | — | — | — | (65,651 | )(R) | 132,046 | ||||||||||||||||
Accounts receivable, net | 38,414 | — | — | — | — | 38,414 | |||||||||||||||||
Cash, cash equivalents and restricted cash | 86,858 | 3,420 | — | 9,054 | — | 99,332 | |||||||||||||||||
Intangible assets, net | 325,859 | — | 13,500 | (E) | 36,530 | 41,845 | (S) | 417,734 | |||||||||||||||
Real estate held for sale, net | 12,554 | — | — | — | — | 12,554 | |||||||||||||||||
Other assets, net | 494,835 | 35,609 | (10,834 | )(F) | 6,242 | (5,742 | )(T) | 520,110 | |||||||||||||||
Total assets | $ | 12,245,299 | $ | 3,162,659 | $ | 1,306,974 | $ | 992,605 | $ | (188,702 | ) | $ | 17,518,835 | ||||||||||
LIABILITIES AND EQUITY | |||||||||||||||||||||||
Bank line of credit | $ | 318,000 | $ | — | $ | 174,300 | (G) | $ | — | $ | — | $ | 492,300 | ||||||||||
Bridge loan facility | — | — | 950,000 | (G) | — | — | 950,000 | ||||||||||||||||
Senior unsecured notes | 3,324,975 | — | 1,500,000 | (G) | — | — | 4,824,975 | ||||||||||||||||
Mortgage and other secured debt | 1,682,740 | — | (424,720 | )(G) | 652,036 | 314 | (U) | 1,910,370 | |||||||||||||||
Long-term debt | — | 4,595,942 | (4,595,942 | )(G) | — | — | — | ||||||||||||||||
Other debt | 93,990 | — | — | — | — | 93,990 | |||||||||||||||||
Intangible liabilities, net | 153,522 | — | — | 989 | (989 | )(V) | 153,522 | ||||||||||||||||
Accounts payable and accrued expenses and deferred revenues | 418,288 | 1,048,549 | (931,259 | )(H) | 7,781 | (543 | )(R) | 542,816 | |||||||||||||||
Total liabilities | 5,991,515 | 5,644,491 | (3,327,621 | ) | 660,806 | (1,218 | ) | 8,967,973 | |||||||||||||||
Equity: | |||||||||||||||||||||||
Preferred stock | 285,173 | — | — | — | — | 285,173 | |||||||||||||||||
Common stock | 310,507 | — | 41,545 | (I) | — | 4,455 | (I) | 382,216 | |||||||||||||||
25,709 | (J) | ||||||||||||||||||||||
Additional paid-in capital | 6,237,663 | — | 1,233,772 | (I) | — | 132,348 | (I) | 8,429,474 | |||||||||||||||
825,691 | (J) | ||||||||||||||||||||||
Cumulative dividends in excess of earnings | (761,036 | ) | — | 44,921 | (D) | — | 7,662 | (Q) | (727,478 | ) | |||||||||||||
— | — | (18,875 | )(B) | — | (150 | )(P) | — | ||||||||||||||||
Accumulated other comprehensive loss | (7,426 | ) | — | — | — | — | (7,426 | ) | |||||||||||||||
Total members' equity (deficit) | — | (2,481,832 | ) | 2,481,832 | (B) | 331,799 | (331,799 | )(P) | — | ||||||||||||||
Total stockholders' equity | 6,064,881 | (2,481,832 | ) | 4,634,595 | 331,799 | (187,484 | ) | 8,361,959 | |||||||||||||||
Total noncontrolling interests | 188,903 | — | — | — | — | 188,903 | |||||||||||||||||
Total equity | 6,253,784 | (2,481,832 | ) | 4,634,595 | 331,799 | (187,484 | ) | 8,550,862 | |||||||||||||||
Total liabilities and equity | $ | 12,245,299 | $ | 3,162,659 | $ | 1,306,974 | $ | 992,605 | $ | (188,702 | ) | $ | 17,518,835 | ||||||||||
The accompanying notes are an integral part of these
unaudited pro forma condensed consolidated financial statements.
3
HCP, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
NINE MONTHS ENDED SEPTEMBER 30, 2010
| HCP Historical | HCR ManorCare PropCo Historical (A) | HCR ManorCare PropCo Pro Forma Adjustments | HCP Ventures II Historical (A) | HCP Ventures II Pro Forma Adjustments (P) | HCP Pro Forma | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands, except per share data) | ||||||||||||||||||||
Revenues and other income: | |||||||||||||||||||||
Rental and related revenues | $ | 697,802 | $ | — | $ | — | $ | 58,003 | $ | (7,216 | )(W) | $ | 748,589 | ||||||||
Tenant recoveries | 67,262 | — | — | — | — | 67,262 | |||||||||||||||
Income from direct financing leases | 37,238 | 331,865 | 143,334 | (K) | — | — | 512,437 | ||||||||||||||
Interest income | 108,004 | — | (83,819 | )(L) | 1 | — | 24,186 | ||||||||||||||
Investment management fee income | 3,755 | — | — | — | (1,965 | )(X) | 1,790 | ||||||||||||||
Total revenues | 914,061 | 331,865 | 59,515 | 58,004 | (9,181 | ) | 1,354,264 | ||||||||||||||
Costs and expenses: | |||||||||||||||||||||
Depreciation and amortization | 234,008 | — | — | 20,760 | 3,345 | (Y) | 258,113 | ||||||||||||||
Interest expense | 220,303 | 116,183 | (17,326 | )(M) | 28,637 | (454 | )(Z) | 347,343 | |||||||||||||
Operating | 152,028 | 1,274 | (1,159 | )(N) | 15 | — | 152,158 | ||||||||||||||
General and administrative | 65,039 | — | — | 3,330 | (3,209 | )(X) | 65,160 | ||||||||||||||
Impairments (recoveries) | (11,900 | ) | — | — | 54,500 | (54,500 | )(AA) | (11,900 | ) | ||||||||||||
Total costs and expenses | 659,478 | 117,457 | (18,485 | ) | 107,242 | (54,818 | ) | 810,874 | |||||||||||||
Other income, net | 7,151 | (10,921 | ) | 10,921 | — | — | 7,151 | ||||||||||||||
Income before income taxes and equity income from and impairments of investments in unconsolidated joint ventures | 261,734 | 203,487 | 88,921 | (49,238 | ) | 45,637 | 550,541 | ||||||||||||||
Income taxes | (1,809 | ) | (76,923 | ) | 76,923 | (O) | — | — | (1,809 | ) | |||||||||||
Equity income from unconsolidated joint ventures | 4,078 | — | — | — | (2,749 | )(BB) | 1,329 | ||||||||||||||
Impairments of investments in unconsolidated joint ventures | (71,693 | ) | — | — | — | 71,693 | (BB) | — | |||||||||||||
Income from continuing operations | 192,310 | 126,564 | 165,844 | (49,238 | ) | 114,581 | 550,061 | ||||||||||||||
Noncontrolling interests' share of earnings | (10,077 | ) | — | — | — | — | (10,077 | ) | |||||||||||||
Income from continuing operations applicable to HCP, Inc. | 182,233 | 126,564 | 165,844 | (49,238 | ) | 114,581 | 539,984 | ||||||||||||||
Preferred stock dividends | (15,848 | ) | — | — | — | — | (15,848 | ) | |||||||||||||
Participating securities' share in earnings | (1,648 | ) | — | — | — | — | (1,648 | ) | |||||||||||||
Income from continuing operations applicable to common shares | $ | 164,737 | $ | 126,564 | $ | 165,844 | $ | (49,238 | ) | $ | 114,581 | $ | 522,488 | ||||||||
Income from continuing operations per common share—basic(CC) | $ | 0.55 | $ | 1.41 | |||||||||||||||||
Income from continuing operations per common share—diluted(CC) | $ | 0.55 | $ | 1.40 | |||||||||||||||||
Weighted average shares used to calculate income per common share: | |||||||||||||||||||||
Basic(CC) | 299,243 | 67,254 | (DD) | 4,455 | (DD) | 370,952 | |||||||||||||||
Diluted(CC) | 300,468 | 67,254 | (DD) | 4,455 | (DD) | 372,177 | |||||||||||||||
The accompanying notes are an integral part of these
unaudited pro forma condensed consolidated financial statements.
4
HCP, INC.
UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
YEAR ENDED DECEMBER 31, 2009
| HCP Historical | HCR ManorCare PropCo Historical (A) | HCR ManorCare PropCo Pro Forma Adjustments | HCP Ventures II Historical (A) | HCP Ventures II Pro Forma Adjustments (P) | HCP Pro Forma | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands, except per share data) | ||||||||||||||||||||
Revenues and other income: | |||||||||||||||||||||
Rental and related revenues | $ | 878,770 | $ | — | $ | — | $ | 83,510 | $ | (10,084 | )(W) | $ | 952,196 | ||||||||
Tenant recoveries | 89,582 | — | — | — | — | 89,582 | |||||||||||||||
Income from direct financing leases | 51,495 | 438,876 | 182,441 | (K) | — | — | 672,812 | ||||||||||||||
Interest income | 124,146 | — | (81,054 | )(L) | 1 | — | 43,093 | ||||||||||||||
Investment management fee income | 5,312 | — | — | — | (2,789 | )(X) | 2,523 | ||||||||||||||
Total revenues | 1,149,305 | 438,876 | 101,387 | 83,511 | (12,873 | ) | 1,760,206 | ||||||||||||||
Costs and expenses: | |||||||||||||||||||||
Depreciation and amortization | 316,803 | — | — | 28,038 | 4,101 | (Y) | 348,942 | ||||||||||||||
Interest expense | 298,897 | 152,316 | (8,025) | (M) | 38,778 | (605 | )(Z) | 481,361 | |||||||||||||
Operating | 185,829 | 1,802 | (1,649 | )(N) | 7 | — | 185,989 | ||||||||||||||
General and administrative | 78,471 | — | — | 4,682 | (4,291 | )(X) | 78,862 | ||||||||||||||
Litigation provision | 101,973 | — | — | — | — | 101,973 | |||||||||||||||
Impairments (recoveries) | 75,389 | — | — | — | — | 75,389 | |||||||||||||||
Total costs and expenses | 1,057,362 | 154,118 | (9,674 | ) | 71,505 | (795 | ) | 1,272,516 | |||||||||||||
Other income, net | 7,768 | (5,757 | ) | 5,757 | — | — | 7,768 | ||||||||||||||
Income before income taxes and equity income from and impairments of investments in unconsolidated joint ventures | 99,711 | 279,001 | 116,818 | 12,006 | (12,078 | ) | 495,458 | ||||||||||||||
Income taxes | (1,910 | ) | (105,408 | ) | 105,408 | (O) | — | — | (1,910 | ) | |||||||||||
Equity income from unconsolidated joint ventures | 3,511 | — | — | — | (5,541 | )(BB) | (2,030 | ) | |||||||||||||
Income from continuing operations | 101,312 | 173,593 | 222,226 | 12,006 | (17,619 | ) | 491,518 | ||||||||||||||
Noncontrolling interests' share of earnings | (14,461 | ) | — | — | — | — | (14,461 | ) | |||||||||||||
Income from continuing operations applicable to HCP, Inc. | 86,851 | 173,593 | 222,226 | 12,006 | (17,619 | ) | 477,057 | ||||||||||||||
Preferred stock dividends | (21,130 | ) | — | — | — | — | (21,130 | ) | |||||||||||||
Participating securities' share in earnings | (1,491 | ) | — | — | — | — | (1,491 | ) | |||||||||||||
Income from continuing operations applicable to common shares | $ | 64,230 | $ | 173,593 | $ | 222,226 | $ | 12,006 | $ | (17,619 | ) | $ | 454,436 | ||||||||
Income from continuing operations per common share—basic(CC) | $ | 0.23 | $ | 1.31 | |||||||||||||||||
Income from continuing operations per common share—diluted(CC) | $ | 0.23 | $ | 1.31 | |||||||||||||||||
Weighted average shares used to calculate income per common share: | |||||||||||||||||||||
Basic(CC) | 274,216 | 67,254 | (DD) | 4,455 | (DD) | 345,925 | |||||||||||||||
Diluted(CC) | 274,631 | 67,254 | (DD) | 4,455 | (DD) | 346,340 | |||||||||||||||
The accompanying notes are an integral part of these
unaudited pro forma condensed consolidated financial statements.
5
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS
The unaudited pro forma condensed consolidated financial statements should be read in conjunction with the respective historical financial statements and the notes thereto of HCP and HCR ManorCare PropCo for the year ended December 31, 2009 and as of and for the nine months ended September 30, 2010 that are incorporated herein by reference.
The calculation of the HCR ManorCare Facilities Acquisition total purchase price follows (in thousands):
| September 30, 2010 | |||||
---|---|---|---|---|---|---|
Calculation of HCR ManorCare PropCo purchase price | ||||||
Issuance of 25.7 million shares of HCP common stock | $ | 852,000 | ||||
Payment of aggregate cash consideration, net of cash acquired | 3,432,227 | |||||
HCP's loan investment in HCR ManorCare PropCo's debt settled at fair value | 1,623,618 | |||||
Assumed HCR ManorCare PropCo accrued tax and other liabilities at fair value | 117,290 | |||||
Total purchase price | $ | 6,025,135 | ||||
Estimated fees and costs | ||||||
Advisory fees(1) | $ | 12,600 | ||||
Legal, accounting and other fees and costs(1) | 6,275 | |||||
Share registration rights | 600 | |||||
Debt issuance costs | 19,775 | |||||
Total | $ | 39,250 | ||||
Adjustment to the total members' deficit represents the elimination of such historical deficit balance of HCR ManorCare PropCo.
6
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Elimination of HCR ManorCare PropCo's historical deferred debt issuance costs | $ | (35,442 | ) | ||
Elimination of HCR ManorCare PropCo's land parcel not acquired at closing | (60 | ) | |||
Elimination of HCR ManorCare PropCo's derivative asset settled at closing | (107 | ) | |||
Fair value of option to purchase a non-controlling interest in the lessee | 5,000 | ||||
Deferral of debt issuance costs associated with new borrowings | 19,775 | ||||
$ | (10,834 | ) | |||
Elimination of HCR ManorCare PropCo's historical deferred tax liability | $ | (907,248 | ) | ||
Payment of HCR ManorCare's historical accrued interest on its long-term debt | (7,746 | ) | |||
Elimination of HCR ManorCare PropCo's net payable to its affiliate | (16,265 | ) | |||
$ | (931,259 | ) | |||
At closing of the HCR ManorCare Facilities Acquisition, HCP will not be responsible for HCR ManorCare PropCo's recorded amounts of the deferred tax obligations; accordingly, such deferred tax obligations amounts were eliminated.
7
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
$1.4 billion to fund a portion of the cash consideration and other associated costs of the Acquisitions. HCP used $137 million to fund the HCP Ventures II Purchase with the remaining balance of approximately $1.3 billion to be used to partially fund the HCR ManorCare Facilities Acquisition. The shares of HCP common stock issued in connection with the December 2010 equity offering are valued as follows (in thousands, except share and per share data):
Number of shares issued | 46,000,000 | |||||
Price of shares of HCP common stock | $ | 32.00 | (1) | |||
Value of shares issued | $ | 1,472,000 | ||||
Less: Underwriting discount | (58,880 | ) | ||||
Less: share registration and issuance costs | (1,000 | ) | ||||
Total value of shares issued | $ | 1,412,120 | ||||
The total value of the shares of HCP common stock issued is presented as follows:
Par value, $1.00 per share | $ | 46,000 | |||
Additional paid-in capital | 1,366,120 | ||||
$ | 1,412,120 | ||||
Number of shares issued | 25,709,113 | |||||
Assumed price of shares of HCP common stock | $ | 33.14 | (1) | |||
Value of shares issued | $ | 852,000 | ||||
Less: share registration and issuance costs | (600 | ) | ||||
Total value of shares issued | $ | 851,400 | ||||
The total value of the shares of HCP common stock issued is presented as follows:
Par value, $1.00 per share | $ | 25,709 | |||
Additional paid-in capital | 825,691 | ||||
$ | 851,400 | ||||
8
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Eliminate HCR ManorCare PropCo historical income from DFLs | $ | (331,865 | ) | $ | (438,876 | ) | ||
Pro forma amortization of unearned income from DFLs under the effective interest method | 475,199 | 621,317 | ||||||
$ | 143,334 | $ | 182,441 | |||||
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Interest expense and related amortization of issuance costs and fees associated with new borrowings used to finance the HCR ManorCare Facilities Acquisition (See Note G) | $ | 103,004 | $ | 146,521 | ||||
Eliminate HCR ManorCare PropCo's historical interest expense | (116,183 | ) | (152,316 | ) | ||||
Eliminate HCP's historical interest expense related to debt repaid at closing that is secured by HCP's loan investment participation in HCR ManorCare PropCo's mortgage debt | (4,147 | ) | (2,230 | ) | ||||
$ | (17,326 | ) | $ | (8,025 | ) | |||
The pro forma increase in interest expense as a result of the assumed issuance of new debt in the HCR ManorCare Facilities Acquisition is calculated using market rates management believes would have been available to HCP for the borrowings assumed to have been issued as of December 13, 2010 (the date that the definitive agreement was executed to acquire HCR ManorCare PropCo). Each1/8 of 1% increase in the annual interest assumed with respect to the debt would increase pro forma interest expense by $3.3 million for the year ended December 31, 2009 and $2.5 million for the nine months ended September 30, 2010.
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Eliminate HCR ManorCare PropCo's historical operating expenses | $ | (1,274 | ) | $ | (1,802 | ) | ||
Recognize the amortization of acquired ground lease intangibles | 115 | 153 | ||||||
$ | (1,159 | ) | $ | (1,649 | ) | |||
For intangible assets associated with the value of in-place ground leases, a weighted-average remaining lease term of approximately 88 years was used to compute amortization expense. The
9
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Company computes amortization using the straight-line method over the remaining lease term of the related lease.
The calculation of the HCP Ventures II Purchase consideration and total purchase price follows (in thousands):
| September 30, 2010 | |||||
---|---|---|---|---|---|---|
Calculation of HCP Ventures II purchase price | ||||||
Payment of aggregate cash consideration, net of cash acquired | $ | 136,153 | ||||
Fair value of 35 percent interest in HCP Ventures II | 73,313 | |||||
All HCP Ventures II debt assumed at par value | 652,350 | |||||
Total purchase price | $ | 861,816 | ||||
Estimated fees and costs | ||||||
Legal, accounting and other fees and costs(1) | $ | 150 | ||||
Debt assumption fees | 500 | |||||
Total | $ | 650 | ||||
Adjustment to the total members' equity represents the elimination of such historical equity balance of HCP Ventures II.
10
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
Elimination of HCP's historical carrying value of HCP Ventures II | $ | 65,108 | |||
Elimination of historical amounts due from HCP Ventures II | 543 | ||||
65,651 | |||||
Elimination of historical amounts due to HCP Ventures II | $ | 543 | |||
The consolidation of HCP Ventures II results in an estimated gain of $7.7 million, which represents the estimated fair value of HCP's 35 percent noncontrolling interest in HCP Ventures II that is in excess of its carrying value at September 30, 2010. This gain is directly attributable to the transaction and represents a non-recurring credit; therefore, the impact on the results of operations was excluded from the pro forma consolidated statements of operations.
Recognition of lease-up related intangible assets associated with acquired leases | $ | 78,375 | |||
Elimination of HCP Ventures II's historical intangible assets | (36,530 | ) | |||
$ | 41,845 | ||||
In-place lease intangible assets acquired include amounts for in-place lease values that are based on HCP's evaluation of the specific characteristics of each tenant's lease. Factors to be considered include estimates of carrying costs during hypothetical expected lease-up periods, market conditions, and costs to execute similar leases. In estimating carrying costs, HCP includes estimates of lost rentals at market rates during the expected lease-up periods, depending on local market conditions. In estimating costs to execute similar leases, HCP considers leasing commissions, legal and other related costs.
Deferral of debt issuance costs associated with debt assumed in the HCP Ventures II Purchase | $ | 500 | |||
Elimination of HCP Ventures II's historical deferred debt issuance | (3,500 | ) | |||
Elimination of HCP Ventures II's leasing incentive assets | (2,742 | ) | |||
$ | (5,742 | ) | |||
11
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Eliminate HCP Ventures II's historical straight-line rent revenue | $ | (9,539 | ) | $ | (13,221 | ) | ||
Eliminate HCP Ventures II's historical amortization of lease intangibles and lease incentives | 2,323 | 3,137 | ||||||
$ | (7,216 | ) | $ | (10,084 | ) | |||
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Eliminate HCP's historical management fee income related to HCP Ventures II | $ | (1,965 | ) | $ | (2,789 | ) | ||
Eliminate HCP Ventures II's historical management fees paid to HCP | $ | 3,209 | $ | 4,291 | ||||
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Real estate depreciation expense as a result of the recording of HCP Ventures II's real estate at its estimated fair value | $ | 17,189 | $ | 22,918 | ||||
Represents the incremental amortization expense related to lease-up related intangible assets associated with acquired leases | 6,916 | 9,221 | ||||||
Eliminate HCP Ventures II's historical depreciation and amortization | (20,760 | ) | (28,038 | ) | ||||
$ | 3,345 | $ | 4,101 | |||||
An estimated useful life of 30 years was assumed to compute real estate depreciation. For assets and liabilities associated with the value of in-place leases, a weighted-average remaining lease term of approximately 8.5 years was used to compute amortization expense. The Company computes depreciation and amortization using the straight-line method over the properties estimated useful lives or the remaining lease term of the related intangible.
12
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | ||||||
---|---|---|---|---|---|---|---|---|
Amortization of debt issuance costs associated with the assumed debt in the HCP Ventures II Purchase | $ | 60 | $ | 80 | ||||
Eliminate HCP Ventures II's historical debt issuance costs amortization | (514 | ) | (685 | ) | ||||
$ | (454 | ) | $ | (605 | ) | |||
13
HCP, INC.
NOTES TO UNAUDITED PRO FORMA CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS (Continued)
| Nine Months Ended September 30, 2010 | Year Ended December 31, 2009 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Historical | Pro Forma | Historical | Pro Forma | |||||||||||
Income from continuing operations | $ | 192,310 | $ | 550,061 | $ | 101,312 | $ | 491,518 | |||||||
Noncontrolling interests' share of earnings | (10,077 | ) | (10,077 | ) | (14,461 | ) | (14,461 | ) | |||||||
Income from continuing operations applicable to HCP, Inc. | $ | 182,233 | $ | 539,984 | $ | 86,851 | $ | 477,057 | |||||||
Preferred stock dividends | (15,848 | ) | (15,848 | ) | (21,130 | ) | (21,130 | ) | |||||||
Participating securities' share in earnings | (1,648 | ) | (1,648 | ) | (1,491 | ) | (1,491 | ) | |||||||
Income from continuing operations applicable to common shares | $ | 164,737 | $ | 522,488 | $ | 64,230 | $ | 454,436 | |||||||
Weighted average shares used to calculate earnings per common share—Basic | 299,243 | 370,952 | 274,216 | 345,925 | |||||||||||
Incremental weighted average effect of potentially dilutive instruments | 1,225 | 1,225 | 415 | 415 | |||||||||||
Adjusted weighted average shares used to calculate earnings per common share—Diluted | 300,468 | 372,177 | 274,631 | 346,340 | |||||||||||
Earnings from continuing operations per common share—Basic | $ | 0.55 | $ | 1.41 | $ | 0.23 | $ | 1.31 | |||||||
Earnings from continuing operations per common share—Diluted | $ | 0.55 | $ | 1.40 | $ | 0.23 | $ | 1.31 | |||||||
14